Elkem (ELK) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Jul, 2026Executive summary
Transformation and cost reduction initiatives are ahead of target, with organizational streamlining and workforce reductions exceeding expectations.
NOK 1.8 billion in new equity raised and main bank facilities refinanced, significantly reducing net debt and improving leverage ratio to 3.2x.
Elkem Iceland reclassified as discontinued operations due to persistent weak results and ongoing strategic review.
New CEO Dag Teigland appointed, effective August 2026, bringing extensive industry experience.
Strong ESG performance, with improved safety metrics and top-tier sustainability ratings.
Financial highlights
Q2 2026 operating income was NOK 3,708 million, down 4% year-over-year, mainly due to lower sales prices.
EBITDA for Q2 2026 was NOK 523 million, down 19% year-over-year, with a margin of 14%.
Net interest-bearing debt at quarter-end was NOK 6,593 million, with a leverage ratio of 3.2x.
EPS for continued operations was NOK -0.15 for the quarter; total EPS was NOK -2.09, mainly due to discontinued operations.
Cash flow from operations was NOK 733 million, a significant year-on-year improvement.
Outlook and guidance
Cost reduction program will continue to contribute positively from Q3 2026 onward, with NOK 600 million annual savings expected.
Third quarter expected to be impacted by seasonally lower activity, especially in Europe.
Trade regulations and protective measures in the EU and U.S. may support demand and price recovery if effective.
New divisional reporting structure to be implemented from Q3 2026.
Carbon Solutions expects stable performance in Q3 2026.
Latest events from Elkem
- EBITDA fell 65% year-over-year as transformation, cost cuts, and refinancing reshape the business.ELK
Q1 20261 May 2026 - Portfolio reshaping and cost cuts position the company for focused growth amid market challenges.ELK
DNB Carnegie Small & Medium Enterprises Conference presentation30 Mar 2026 - Silicones division sale drives transformation, cost cuts, and growth focus amid challenging markets.ELK
JP Morgan European Chemicals Forum presentation30 Mar 2026 - All agenda items, including the Bluestar share deal and capital decrease, were approved.ELK
EGM 20269 Mar 2026 - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 202513 Feb 2026 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 20243 Feb 2026 - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 202418 Jan 2026 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation14 Jan 2026 - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation14 Jan 2026